Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety, and Cost-Effectiveness of Albumin-Bound Paclitaxel (Ⅱ) in Chinese Patients With Advanced Breast Cancer: A Multicenter, Observational, Real-World Study

NCT07899047 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07899047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety, and Cost-Effectiveness of Albumin-Bound Paclitaxel (Ⅱ) in Chinese Patients With Advanced Breast Cancer: A Multicenter, Observational, Real-World Study
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
May 31, 2030
Enrollment
1,372 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, breast cancer, her2-negative breast cancer

Arms

As registered; 2 arms.

  • Experimental Group Experimental Group
  • Control group control group

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Overall Survival (OS) 42 months

    Time from the participant's first study-drug administration to death from any cause.

Lead sponsor's other trials

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, most recent start first.

Similar trials

Same condition (Breast Neoplasms) and phase, most recent start first.